I am a trained biochemist and engineer who specializes in the use of advanced magnetic resonance imaging approaches to study cancer metabolism. I am a faculty member in the Department of Radiology as well as Laboratory Head in the Sloan Kettering Institute’s Molecular Pharmacology Program.
My laboratory focuses on the development of novel biochemical approaches using multi-modality imaging with emphasis in a new field of MRI, hyperpolarized magnetic resonance. These directions include endogenous small molecules to study metabolism, platforms for their interrogation and mechanisms for cancer therapy. Our translational research is aimed at taking these approaches from the bench to bedside to not only conduct fundamental research, but to directly impact the human condition.
- Clinical Expertise: Metabolic and Molecular Imaging
- Languages Spoken: English
- Education: PhD Biomedical Engineering, University of North Carolina
- Fellowships: University of California, San Francisco
As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.Learn more
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more